Olivia Kahn
Nurse Practitioner · Fresno, CANPI 1134684657
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 93.8% of the total across 56 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 29 manufacturers, the largest accounting for just 8.5% — the pattern of someone who eats at a lot of different presentations. 2025 is the largest year on record at $807, 9.9 times the $82 reported in 2021.
Across 56 payments — averaging $28.42 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Novartis$135
- AstraZeneca$133
- Novo Nordisk$125
- Ultragenyx Pharmaceutical Inc.$122
- Sobi, Inc$108
- Medical Device Business Services, Inc.$98
- plus $871 from 23 others
What the payments were for
- Food & beverage$1,49494%
- Education$986%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Novartis | 5 | $135 |
| AstraZeneca | 6 | $133 |
| Novo Nordisk | 1 | $125 |
| Ultragenyx Pharmaceutical Inc. | 1 | $122 |
| Sobi, Inc | 4 | $108 |
| Medical Device Business Services, Inc. | 1 | $98 |
| Pharmaessentia USA Corporation | 3 | $83 |
| Merck | 4 | $82 |
| Daiichi Sankyo Inc. | 3 | $72 |
| AbbVie | 3 | $70 |
| Boehringer Ingelheim | 3 | $60 |
| Lilly USA, LLC | 2 | $53 |
| Ipsen Biopharmaceuticals, Inc | 2 | $46 |
| GSK | 2 | $45 |
| Exelixis Inc. | 1 | $40 |
| Genentech USA, Inc. | 2 | $39 |
| Stemline Therapeutics Inc. | 1 | $37 |
| Tempus AI, Inc | 1 | $28 |
| Genmab U.S., Inc. | 1 | $27 |
| Incyte Corporation | 1 | $25 |
| Jazz Pharmaceuticals Inc. | 1 | $24 |
| Deciphera Pharmaceuticals Inc. | 1 | $23 |
| Optinose US, Inc. | 1 | $22 |
| Bayer | 1 | $20 |
| Gilead | 1 | $18 |
| Novocure Inc. | 1 | $18 |
| Dendreon Pharmaceuticals LLC | 1 | $15 |
| Agios Pharmaceuticals, Inc. | 1 | $14 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $14 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$1,592 in reported general payments places this provider in the 85th percentile of 6,779 nurse practitioner providers in California.
Other nurse practitioner in Fresno
- Erica BedstedFresno$194K
- Sonja GrowcottFresno$31K
- Rhonda HewittStanford$917K
- Linda TrinhIrvine$884K
- Denise SinagaNorthridge$728K
- Debbie TaySanta Monica$642K
- Joe GorelickCampbell$638K
- Lynsey LakinArcadia$540K
- Kelly ChoiRancho Cucamonga$483K
- Hamta ZareStanford$428K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.